Kendall Keith J 4
4 · Aquestive Therapeutics, Inc. · Filed Jul 2, 2020
Insider Transaction Report
Form 4
Kendall Keith J
DirectorCEO and President
Transactions
- Exercise/Conversion
Common Stock
[F1]2020-06-30+333→ 639,297 total - Tax Payment
Common Stock
[F2]2020-06-30$4.86/sh−148$719→ 639,149 total - Exercise/Conversion
Restricted Stock Units
[F1][F3]2020-06-30−333→ 0 totalExercise: $0.00From: 2020-06-30→ Common Stock (333 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock award. The amount retained by the Company was not in excess of the amount of the tax liability.
- [F3]There are no expiration dates on RSUs.
Signature
/s/ Robert Arnold, as Attorney-In-Fact|2020-07-02